DC1: Design and discovery of novel GrnzB ligands and evaluation as diagnostics tools in CAR T cell therapy assessment

DC2: Novel probes for imaging of tumor-associated proteases via Positron Emission Tomography (PET) and fluorescence microscopy

DC3: : Innovative Target Modulators (TMs) for simultaneous delivery of CAR T cell therapy, radio- and chemotherapy to tumors

DC4:  Innovative Target Modulators for FAP-targeting UniCAR T therapy

DC5: Design and discovery of novel cathepsin S ligands and their evaluation as PET and fluorescent probes for oncology diagnosis (

DC6: Characterization of the p38 MAPK pathway in the expression of TME proteases

DC7In vivo investigation of FAP-targeting UniCAR T cell therapies combined with radio- and chemotherapy

DC8: Novel probes for imaging of tumor-associated cathepsins via Positron Emission Tomography (PET) and fluorescence microscopy

DC9: Microfluidics-based, multilevel cellular phenotyping of lymphoma cells and CAR T cells and in vivo validation

DC10:  Innovative in vitro and in vivo models for TME protease research